Increasing the Odds of: “Is This Treatment Going to Work?”

Rusch V Baselga J Cordon-Cardo C Orazem J Zaman M Hoda S . Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. Cancer Res. 1993 May 15;53(10 Suppl):2379–85.

Kosaka T Yatabe Y Endoh H Kuwano H Takahashi T Mitsudomi T . Mutations of the epidermal growth factor receptor gene in lung cancer: Biological and clinical implications. Cancer Res. 2004 Dec 15;64(24):8919–23.

Kim ES Hirsh V Mok T Socinski MA Gervais R Wu YL . Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): A randomised phase III trial. Lancet. 2008 Nov 22;372(9652):1809–18.

Kris MG Natale RB Herbst RS Lynch TJ Jr Prager D Belani CP . Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: A randomized trial. JAMA. 2003 Oct 22;290(16):2149–58.

Shepherd FA Rodrigues Pereira J Ciuleanu T Tan EH Hirsh V Thongprasert S ; National Cancer Institute of Canada Clinical Trials Group. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med. 2005 Jul 14;353(2):123–32.

Trends in Cancer Incidence 1968–2007, Singapore Cancer Registry Report No. 7, Singapore Cancer Registry

Toh CK Gao F Lim WT Leong SS Fong KW Yap SP . Never-smokers with lung cancer: Epidemiologic evidence of a distinct disease entity. J Clin Oncol. 2006 May 20;24(15):2245–51.

Pao W Miller V Zakowski M Doherty J Politi K Sarkaria I . EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA. 2004 Sep 7;101(36):13306–11

Maemondo M Inoue A Kobayashi K Sugawara S Oizumi S Isobe H ; North-East Japan Study Group. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med. 2010 Jun 24;362(25):2380–8.

Ledford H . Big science: The cancer genome challenge. Nature. 2010 Apr 15; 464 (7291): 972–4